AlphaCentric Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.25M | Buy |
+3,101
| New | +$1.25M | 1.25% | 21 |
|
|
2021
Q4 | – | Sell |
-10,250
| Closed | -$1.86M | – | 276 |
|
|
2021
Q3 | $1.86M | Buy |
10,250
+3,000
| +41% | +$544K | 0.47% | 8 |
|
|
2021
Q2 | $1.46M | Buy |
7,250
+3,250
| +81% | +$655K | 0.4% | 12 |
|
|
2021
Q1 | $860K | Buy |
4,000
+2,950
| +281% | +$634K | 0.29% | 26 |
|
|
2020
Q4 | $248K | Buy |
1,050
+1,040
| +10,400% | +$246K | 0.1% | 54 |
|
|
2020
Q3 | $3K | Hold |
10
| – | – | ﹤0.01% | 163 |
|
|
2020
Q2 | $3K | Buy |
+10
| New | +$3K | ﹤0.01% | 144 |
|